These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35569348)

  • 1. Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.
    Guo F; Sun Y; Wang H; Wang H; Zhou J; Fan H; Su J; Gong T; Jiang C; Liang P
    Stem Cell Res; 2022 Jul; 62():102813. PubMed ID: 35569348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant.
    Zhao J; Wang L; Zhu K; Chen X; Qin F; Li X; Dong J; Tao H
    Stem Cell Res; 2022 Aug; 63():102836. PubMed ID: 35700634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
    Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
    Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome).
    Wang B; Ren Q; Cui X; Shan W; Guo X; Wang X; Wang J; Li Y; An G
    Stem Cell Res; 2024 Jun; 77():103400. PubMed ID: 38547667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.
    Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of human embryonic stem cell WAe009-A-88 carrying a long QT syndrome mutation in KCNH2.
    Wen H; Sun L; Zhong J; Wu F
    Stem Cell Res; 2022 Jul; 62():102795. PubMed ID: 35526388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
    Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
    Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of human embryonic stem cell WAe009-A-74 carrying a Long QT syndrome mutation in KCNH2.
    Sun L; Zhong J; Wu F; Li F; Yang X; Zeng Z
    Stem Cell Res; 2022 Apr; 60():102725. PubMed ID: 35247842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.
    Mura M; Mehta A; Ramachandra CJ; Zappatore R; Pisano F; Ciuffreda MC; Barbaccia V; Crotti L; Schwartz PJ; Shim W; Gnecchi M
    Int J Cardiol; 2017 Aug; 240():367-371. PubMed ID: 28433559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
    Caballero R; Utrilla RG; Amorós I; Matamoros M; Pérez-Hernández M; Tinaquero D; Alfayate S; Nieto-Marín P; Guerrero-Serna G; Liu QH; Ramos-Mondragón R; Ponce-Balbuena D; Herron T; Campbell KF; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Delpón E; Tamargo J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E416-E425. PubMed ID: 28049825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human embryonic stem cell line (WAe009-A-43) carrying a Long QT syndrome related mutation in KCNH2 gene.
    Wu X; Zhao Y; Wang X
    Stem Cell Res; 2020 Oct; 48():101976. PubMed ID: 32911324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation reinitiation in c.453delC frameshift mutation of KCNH2 producing functional hERG K+ channels with mild dominant negative effect in the heterozygote patient-derived iPSC cardiomyocytes.
    Park NK; Park SJ; Park YG; Moon SH; Woo J; Kim HJ; Kim SJ; Choi SW
    Hum Mol Genet; 2024 Jan; 33(2):110-121. PubMed ID: 37769355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Short QT Syndrome Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    El-Battrawy I; Lan H; Cyganek L; Zhao Z; Li X; Buljubasic F; Lang S; Yücel G; Sattler K; Zimmermann WH; Utikal J; Wieland T; Ravens U; Borggrefe M; Zhou XB; Akin I
    J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29574456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
    O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2.
    Wang T; Zhou Y; Zhou R; Huang W; Wang J; Li H; Lei M; Tan X; Zhang Y
    Stem Cell Res; 2021 Oct; 56():102509. PubMed ID: 34438161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.
    Fatima A; Ivanyuk D; Herms S; Heilmann-Heimbach S; O'Shea O; Chapman C; Izsvák Z; Farr M; Hescheler J; Šarić T
    Stem Cell Res; 2016 Mar; 16(2):304-7. PubMed ID: 27345990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of two iPSC lines from long QT syndrome patients carrying SNTA1 variants.
    Jimenez-Tellez N; Vera CD; Yildirim Z; Vicente Guevara J; Zhang T; Wu JC
    Stem Cell Res; 2023 Feb; 66():103003. PubMed ID: 36528013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a human-induced pluripotent stem cell line, KSCBi014-A, from a long QT syndrome type 2 patient harboring a KCNH2 mutation.
    Lee Y; Koo SK; Kim JH
    Stem Cell Res; 2021 Dec; 57():102570. PubMed ID: 34678663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell line from a Brugada syndrome patient carrying SCN5A/c.3118G>C mutation.
    Fan H; Su J; Wang X; Wang H; Chen X; Sun Y; Jiang C; Liang P
    Stem Cell Res; 2024 Oct; 80():103529. PubMed ID: 39121653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.